[Intrauterine growth restriction]

Elzbieta Lipecka-Kidawska1, Leszek Gottwald, Katarzyna Niewiadomska-Jarosik

  • 1Klinika Patologii Ciazy. igp@psk2.am.lodz.pl

Przeglad Lekarski
|February 9, 2006
PubMed

Insights

Intrauterine growth restriction (IUGR) affects 1-10% of pregnancies, leading to poorer outcomes. This review covers IUGR causes, diagnosis, monitoring, and neonatal impacts.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Fetal Medicine

Context:

  • Intrauterine growth restriction (IUGR) impacts 1-10% of pregnancies globally.
  • Prevalence doubles in high-risk pregnancies.
  • Associated with adverse obstetric and long-term neonatal outcomes.

Purpose:

  • To review the etiology, diagnostics, and monitoring of IUGR.
  • To outline the consequences of IUGR for neonates.
  • To discuss the impact on the neonatal period.

Summary:

  • IUGR etiology is multifactorial, involving placental insufficiency, genetic factors, and maternal conditions.
  • Diagnostic methods include ultrasound biometry, Doppler velocimetry, and biochemical markers.
  • Monitoring focuses on fetal well-being and timely intervention.

Impact:

  • Improved understanding of IUGR management.
  • Enhanced neonatal care for affected infants.
  • Reduced long-term complications associated with fetal growth restriction.